The results could provide a theoretical basis for clarifying the mechanism of anti-PD-1/PD-L1 or anti-CTLA4 primary drug resistance in colon cancer, and provide a new idea for solving the phenomenon of anti-PD-1/PD-L1 or anti-CTLA4 primary drug resistance in colon cancer. Here, CTLA4 is linked to colonic neoplasm.